Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | TP53 | P04637 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | TTR | P02766 | 3/20 | 0.69 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.58 |
| ▸ | TUBB | P07437 | 2/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.58 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717110 | 0.92 | LMNA (0.75) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL717109 | 0.92 | LMNA (0.75) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL2574065 | 0.90 | LMNA (0.77) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL2574064 | 0.90 | LMNA (0.77) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL13259327 | 0.89 | LMNA (0.81) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL1808387 | 0.87 | MEN1 (0.84) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL1808386 | 0.87 | MEN1 (0.84) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL19422004 | 0.85 | TTR (0.69) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL15340449 | 0.84 | HSD17B10 (0.53) | LMNAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL14003975 | 0.83 | KMT2A (0.48) | LMNAMAPTKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011620-B2 | Lipophenol compounds and uses thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2018-07-03 | — | — | US | disclosed |
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | LCLAT1, CBR1, LPO | LMNA 2350/4885MAPT 4769/4885KDM4E 1163/4885 |
| US-10011620-B2 | Lipophenol compounds and uses thereof | LPO, CBR1, LCLAT1 | LMNA 2273/4885MAPT 4789/4885KDM4E 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.